Iloprost therapy in patients with critical limb ischemia
Monitoring efficacy and safety aspects of iv. iloprost therapy of patients with critical limb ischemia by recording clinical parameters.
- Patients who fulfill the internationally defined criteria of critical limb ischemia; - Patients who are not eligible for vascular surgery or angioplasty interventions and - Patients who are treated with iloprost infusion. - The treating physician has decided iloprost treatment before study enrollment.
- Exclusion criteria are in accordance with the Summary of Product Characteristics of Ilomedin.
Many locations, Hungary
E-mail: [email protected]
Phone: Not Available
Iloprost therapy in patients with critical limb ischemia: evaluation of efficacy and safety